1 citations
,
March 2023 in “European Journal of Human Genetics” This retrospective study observed that patients with vascular EDS on long-term angiotensin II receptor blockers or beta-blockers experienced fewer vascular events compared to those without cardiac medication under similar lifestyle and emergency care advice.
September 2026 in “Journal of Cutaneous Medicine and Surgery” This study reviewed cases of ocular adverse events linked to minoxidil use, finding central serous chorioretinopathy as the most common issue, with symptoms improving after discontinuation in many cases, yet causality remains uncertain.
December 2025 in “Biomedicines” This source reviews the common skin-related side effects of tyrosine kinase inhibitors in treating endocrine cancers and emphasizes that proactive, multidisciplinary management can effectively control these adverse events without compromising cancer treatment efficacy.
September 2023 in “Journal of the American Academy of Dermatology” This study found that the incidence of major adverse cardiovascular events in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis who received Ixekizumab was low and stable over 3 to 5 years across 25 clinical trials.
419 citations
,
May 2002 in “British journal of dermatology/British journal of dermatology, Supplement” This study reports cases of arterial embolization occurring due to the injection of hyaluronic acid (Restylane®).